What is the Syneos Health Rare Disease Consortium?
At Syneos Health, helping our clients develop the medicines people need is something we take personally. The Rare Disease Consortium is part of our mission to support patient access to treatment.
Le développement clinique des maladies rares présente des défis très spécifiques qui nécessitent une approche innovante afin de permettre un accès rapide aux options de traitement pour les patients vivant avec une maladie rare.
We understand the sense of urgency to accelerate development of rare disease treatments and to facilitate access to medicines for these patients. This is why Syneos Health created a consortium of experts to support clinical development strategies tailored to specific rare diseases, by focusing on the needs of these special patients to encourage their participation in clinical trials.
We believe that it is our responsibility to develop highly tailored strategies aimed at managing the potential challenges that rare disease studies can present, to ensure that every single patient with a rare disease has the option to access a potential treatment through participation in a clinical trial.
